• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BECTON DICKINSON, S.A. BD POSIFLUSH SP PRE-FILLED FLUSH SYRINGE NACL 0.9%; SALINE VASCULAR ACCESS FLUSH

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BECTON DICKINSON, S.A. BD POSIFLUSH SP PRE-FILLED FLUSH SYRINGE NACL 0.9%; SALINE VASCULAR ACCESS FLUSH Back to Search Results
Catalog Number 306575
Device Problem Leak/Splash (1354)
Patient Problem Chemical Exposure (2570)
Event Date 04/21/2020
Event Type  malfunction  
Manufacturer Narrative
Device evaluation is anticipated, but has not yet begun.Upon completion of the investigation, a supplemental report will be filed.
 
Event Description
It was reported that the bd posiflush¿ sp pre-filled flush syringe nacl 0.9% was aspirating during use while attached to the "cvc lumen with tego caps" when blood pulled through it and splashed/squirted onto the writer and patient's hands.The following information was provided by the initial reporter: "aspirated using this syringe while still attached to pt's cvc lumen with tego caps, blood pulled through syringe and splashed/squirted onto writer and patients hands.".
 
Event Description
It was reported that the bd posiflush¿ sp pre-filled flush syringe nacl 0.9% was aspirating during use while attached to the "cvc lumen with tego caps" when blood pulled through it and splashed/squirted onto the writer and patient's hands.The following information was provided by the initial reporter: "aspirated using this syringe while still attached to pt's cvc lumen with tego caps, blood pulled through syringe and splashed/squirted onto writer and "patient's" hands.".
 
Manufacturer Narrative
H.6.Investigation: a device history record review was performed for provided lot number 9325904.The review did not reveal any detected quality issues during the production process that could have contributed to this reported incident and all inspections were found to be within specification.As samples were unavailable for return, our quality team was unable to perform a thorough sample investigation.Posiflush sp syringes are intended to be used to clean only in-situ vascular access devices (vad) by flushing the saline solution through the catheter into the vein.Once done, the syringe must be disposed of since it is for single use only.According to the reported issue, the syringe was used to aspire, so blood was pulled through the syringe passing the stopper and splashing on patient and user.Therefore, it can be determined that the syringe was misused.At this time, corrective action has not been determined necessary.It is important to carefully follow the instructions for use when using the posiflush product.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BD POSIFLUSH SP PRE-FILLED FLUSH SYRINGE NACL 0.9%
Type of Device
SALINE VASCULAR ACCESS FLUSH
Manufacturer (Section D)
BECTON DICKINSON, S.A.
cr mequinenza
s/n
fraga
MDR Report Key10083196
MDR Text Key194336288
Report Number3002682307-2020-00165
Device Sequence Number1
Product Code NGT
Combination Product (y/n)N
PMA/PMN Number
NA
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,other,user facility
Type of Report Initial,Followup
Report Date 06/23/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Other
Device Expiration Date10/31/2022
Device Catalogue Number306575
Device Lot Number9325904
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 05/04/2020
Initial Date FDA Received05/22/2020
Supplement Dates Manufacturer Received05/04/2020
Supplement Dates FDA Received06/24/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Other;
-
-